Aurinia Pharmaceuticals Inc (AUPH) financials · P/E 7.2, $1.03B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Aurinia Pharmaceuticals Inc (AUPH) P/E 7.2, $1.03B cap.
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Revenue | $83.2M | $77.7M |
| Cost of Revenue | $6.55M | $6.50M |
| Gross Profit | $76.7M | $71.2M |
| Operating Income | $46.3M | $41.4M |
| Net Income | $37.4M | $34.4M |
| EPS (Diluted) | $0.28 | $0.25 |
| Line | Q2 2026 | Q1 2026 |
|---|---|---|
| Total Assets | $792.3M | $724.0M |
| Current Assets | $541.3M | $480.2M |
| Cash & Equivalents | $179.7M | $40.7M |
| Inventory | $45.2M | $46.4M |
| PP&E | $1.86M | $1.99M |
| Total Liabilities | $177.4M | $156.4M |
| Current Liabilities | $99.9M | $86.6M |
| Shareholders' Equity | $614.9M | $567.6M |
| Retained Earnings | -$577.6M | -$615.0M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $135.7M | $44.4M |
| Investing Cash Flow | -$32.8M | $39.3M |
| Financing Cash Flow | -$106.1M | -$49.1M |
| Net Change in Cash | -$3.22M | $34.6M |
FAQ
What is AUPH P/E and revenue?
Aurinia Pharmaceuticals Inc (AUPH) P/E 7.2, $1.03B cap.
What is AUPH revenue?
Aurinia Pharmaceuticals Inc last cached revenue is $83.2M (Q2 2026).
Is AUPH profitable?
Aurinia Pharmaceuticals Inc last cached net income is $37.4M (Q2 2026).
What are AUPH total assets?
Aurinia Pharmaceuticals Inc last cached total assets are $792.3M (Q2 2026).
What is AUPH free cash flow?
No cached cash-flow row for AUPH yet.
Not investment advice. Cached statements, not a live tape.